<DOC>
	<DOCNO>NCT00535652</DOCNO>
	<brief_summary>The purpose study determine tissue kinetics ertapenem colonic tissue three hour six hour ( 25 % dose interval ) administration ertapenem .</brief_summary>
	<brief_title>Concentration Ertapenem Colorectal Tissue</brief_title>
	<detailed_description>The purpose study determine tissue kinetics ertapenem colorectal tissue three hour six hour ( 25 % dose interval ) administration ertapenem elective surgical intervention ( open laparoscopic surgery ) colon/rectum . Subjects patient . Hospitalized patient 18 year old require elective surgical intervention ( open laparoscopic surgery ) colon eligible study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Diverticulum</mesh_term>
	<mesh_term>Diverticulosis , Colonic</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Hospitalized patient 18 year old require elective surgical intervention ( open laparoscopic surgery ) colon eligible study . Patients benignant disorder ( e.g . colonic diverticulosis ) prefer . Pregnancy lactation woman Emergency surgery , history serious allergy intolerance βlactam antibiotic carbapenems Systemic antimicrobial therapy ceftazidime ( internal standard highperformance liquid chromatography / mass spectrometry ) within 7 day period prior study entry Ongoing intraabdominal infection Terminal illness Chronic immunosuppressive therapy Severe diseases liver , e.g . cirrhosis liver ALT AST &gt; 6 x upper limit normal ( ULN ) bilirubin &gt; 3 x ULN , severe renal insufficiency creatinine clearance ≤30 mL/min. , neutrophil count &lt; 1000 cells/mm3 , platelet &lt; 75000 cells/mm3 coagulation study ( INR ) &gt; 1.5 x ULN , ongoing therapy valproin acid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>